Connect with us
Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company’s weight loss obesity shot CagriSema, which delivered less weight...
Dr. Demetre Daskalakis, a former top CDC official, discusses the recent study. — Subscribe to ABC News on YouTube: https://abcnews.visitlink.me/59aJ1G ABC News Digital is your daily...
Novo Nordisk A/S won approval to sell a pill version of its obesity shot Wegovy in the US. Novo will start selling the pill, the first...
A next-generation obesity shot from Eli Lilly helped patients lose nearly a quarter of their body weight, potentially making the experimental drug the most potent weight-loss...
Get a jump start on the US trading day with Matt Miller and Dani Burger on “Bloomberg Open Interest.” Today, visa chaos as Trump targets H-1B...
Aug.05 — Lars Fruergaard Jorgensen, Novo Nordisk chief executive officer, discusses first half earnings results. The Danish … source
For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss...
Ben Rader co-authored the study, which suggests the decrease might be due, in part, to the rise of weight loss drugs like Ozempic. Subscribe to ABC...
Amgen’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the … source
Eli Lilly chairman and CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg’s...
On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.